re: Ann: Key Licence Provided by NewSouth Inn...
My understanding is that's its a new patent and a new licence for treating cancer with their drug plus traditional chemo drugs.
Second two paragraphs state:
The discovery relates to the significant enhancement of the anti-cancer activity of certain well-established mainstream approved cancer drugs without simultaneously enhancing the associated side-effect profile occurring through the killing of normal-dividing cells; a factor that often limits the therapeutic value and utility of chemotherapy.
PharmAust is proceeding to undertake further work on this discovery as part of its development of its key anti-cancer product, PPL-1.
PAA Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)